As tariffs loom over the sector, biotechs with U.S.-based manufacturing and intellectual property are soothing investor ...

Kepler Capital analyst Nicolas Pauillac maintained a Buy rating on BB Biotech (0JYO – Research Report) on April 25 and set a price target of ...

Mid Cap Biotechnology Analyst Joseph and European Pharmaceuticals Analyst Gordon, along with Dr. Hogarth, Prof of Medicine in Pulmonary & ...